Disclosure-in Agreement Sample Contracts

AMENDMENT NO. 2 TO THE CONFIDENTIAL DISCLOSURE-IN AGREEMENT

Disclosure-in Agreement • March 4th, 2021 • Merck & Co., Inc. • Pharmaceutical preparations

• Contract Type
  Disclosure-in Agreement
• Filed
  March 4th, 2021
• Company
  Merck & Co., Inc.
• Industry
  Pharmaceutical preparations

THIS AMENDMENT NO. 2 TO THE CONFIDENTIAL DISCLOSURE AGREEMENT (this “Amendment No. 2”) is entered into as of December 18, 2020 (the “Amendment No. 2 Effective Date”), confirms the mutual understanding between Merck Sharp & Dohme Corp., having a place of business at 33 Avenue Louis Pasteur, Boston, Massachusetts 02115 USA (“Merck”) and Pandion Therapeutics, Inc., having a place of business at 134 Coolidge Ave., Watertown, MA 02472 (“Discloser”). Merck and the Discloser may be referred to herein individually as a “Party” or together as the “Parties”.